Regulation of gene expression by tissue-specific transcription factors involves both turning on and turning off transcription of target genes. Runx3, a runt-domain transcription factor, regulates cell-intrinsic functions by activating and repressing gene expression in sensory neurons, dendritic cells (DC), and T cells. To investigate the mechanism of Runx3-mediated repression in an in vivo context, we generated mice expressing a mutant Runx3 lacking the C-terminal VWRPY, a motif required for Runx3 interaction with the corepressor Groucho͞transducin-like Enhancer-ofsplit (TLE). In contrast with Runx3 ؊/؊ mice, which displayed ataxia due to the death of dorsal root ganglia TrkC neurons, Runx3 VWRPY؊/؊ mice were not ataxic and had intact dorsal root ganglia neurons, indicating that ability of Runx3 to tether Groucho͞TLE is not essential for neurogenesis. In the DC compartment, the mutant protein Runx3 VWRPY؊ promoted normally developed skin Langerhans cells but failed to restrain DC spontaneous maturation, indicating that this latter process involves Runx3-mediated repression through recruitment of Groucho͞TLE. Moreover, in CD8 ؉ thymocytes, Runx3 VWRPY؊ up-regulated ␣E͞CD103-like WT Runx3, whereas unlike wild type, it failed to repress ␣E͞CD103 in CD8 ؉ splenocytes. Thus, in CD8-lineage T cells, Runx3 regulates ␣E͞CD103 in opposing regulatory modes and recruits Groucho͞TLE to facilitate the transition from activation to repression. Runx3 VWRPY؊ also failed to mediate the epigenetic silencing of CD4 gene in CD8 ؉ T cells, but normally regulated other pan-CD8 ؉ T cell genes. These data provide evidence for the requirement of Groucho͞TLE for Runx3-mediated epigenetic silencing of CD4 and pertain to the mechanism through which other Runx3-regulated genes are epigenetically silenced.
M
ammalian Runx3 is one of three transcription factors that comprise the RUNX family (1) (2) (3) (4) . RUNX proteins regulate lineage-specific gene expression in developmental pathways (2, 3) and also could be involved in autoimmune diseases (5) . Loss of Runx3 function is associated with defects in neurogenesis and thymopoiesis, and with the development of colitis, gastritis, and asthma-like features (6) (7) (8) (9) (10) (11) (12) (13) . Regulation of gene expression by tissue-specific transcription factors involves both turning on and turning off transcription of target genes. Runx3 acts as a bifunctional regulator, which up-regulates but also down-regulates, gene expression (14) . How does Runx3 act in vivo both as an activator and a repressor of target genes?
It is believed that a DNA-bound Runx3 elicits repression by tethering corepressors such as the transducin-like Enhancer-of-split (TLE) (15) , the mammalian homolog of Drosophila Groucho (Gro) (16) , to a subset of target promoters (14, 17, 18) . However, the biological significance and in vivo targets of Runx3-mediated transcriptional repression are largely unknown. We (19) and others (20) have shown that both Runx1 and Runx3 interact with the corepressor Gro͞TLE through a conserved motif of five amino acids VWRPY, located at the C terminus of RUNX proteins. Gene knockouts of Runx1 and Runx3 demonstrated that during thymopoiesis, they act as transcriptional repressors of CD4 and as growth regulators of CD8-lineage T lymphocytes (11, 12, 21) . Rescue experiments by using in vitro-cultured fetal liver cells and knock-in chimera mice have indicated that the VWRPY motif of Runx1 plays a role during early T cell development in regulation of CD4 expression and T cell homeostasis (22, 23) . On the other hand, using enforced expression by a retroviral system in organ cultures indicated that the VWRPY motif was not required for either Runx1-or Runx3-mediated repression of CD4 (24) . To resolve this discrepancy and study the mechanism of Runx3-mediated repression of negatively regulated target genes in vivo, we generated mice expressing a mutant Runx3 lacking the VWRPY motif (Runx3 VWRPYϪ ). Using mice homozygous for the mutant allele (Runx3 VWRPYϪ/Ϫ mice) in comparison with WT and null (Runx3 Ϫ/Ϫ ) mice, we derived previously unavailable information on the positive and negative functions of Runx3 in the in vivo context of the animal. Gro͞TLE-dependent and -independent functions of Runx3 now are demonstrated in dorsal root ganglia (DRG) TrkC sensory neurons, dendritic cells (DC), and CD8-lineage T lymphocytes, and CD8 ϩ T cell-specific target genes, whose regulation by Runx3 requires the recruitment of Gro͞TLE, are identified.
We show that in contrast to Runx3 Ϫ/Ϫ mice that display ataxia and growth retardation (9), Runx3 VWRPYϪ/Ϫ mice grew normally and were not ataxic, indicating that the ability of Runx3 to recruit Gro͞TLE is not essential for these processes. Runx3 plays an important role in DC development (7) . DC are bone marrowderived cells specialized in uptake, processing, and presentation of antigens to T cells (25) and play an important role in maintenance of self-tolerance (26) . Tissue-resident DC are normally maintained at an immature state by immunosuppressive cytokines such as TGF-␤, secreted by the surrounding cellular environment (26) . In DC compartment, Runx3 functions as a component in the TGF-␤ signaling pathway and has a dual role: It promotes development of epidermal Langerhans cells (LC), a distinct skin DC population, and restrains maturation of tissue-resident DC (7). Runx3 VWRPYϪ was able to promote LC development but failed to restrain DC maturation, indicating that this latter function involves interactions of Runx3 with Gro͞TLE.
During T cell development, the mutant Runx3 VWRPYϪ positively regulated ␣E͞CD103 expression in CD8 ϩ thymocytes, as was previously reported for WT Runx3 (27) . However, unlike WT Runx3, the mutant failed to repress ␣E͞CD103 in peripheral CD8 ϩ T cells. These data demonstrate that within the same cell lineage, Runx3 regulates the same gene in opposing regulatory modes, and that the mechanism underlying the transition from activation to repression requires recruitment of Gro͞TLE. Moreover, in developing CD8 ϩ T cells, Runx3
VWRPYϪ was unable to repress the CD4 gene, which is otherwise epigenetically silenced (11, (28) (29) (30) but regulated normally the expression of other pan-CD8 ϩ T-cell genes. These data provide evidence for Gro͞TLE requirement for Runx3-mediated epigenetic silencing of CD4 and pertain to the mechanism through which other Runx3-regulated genes are epigenetically silenced.
Results

Expression of Runx3 VWRPY؊ Protein and Phenotypic Features of
Runx3 VWRPY؊/؊ Mice. To obtain Runx3 VWRPYϪ/Ϫ mice, we first generated a mutant allele Runx3 VWRPYϪ , in which the codons of the five C-terminal amino acids VWRPY, were changed to the stop codon UAG and to codons encoding substituted amino acids designed to create a new NotI site (Fig. 1 A; see also Fig. 5 , which is published as supporting information on the PNAS web site). To facilitate selection of positive ES cells, a lox-P-flanked neomycin (neo) cassette was inserted into intron no. 5 (Fig. 1A) . Chimeric mice were generated and used to pass on the mutant Runx3 VWRPYϪ through the germ line. To eliminate potential phenotypic effects caused by the neo gene, it was removed by crossing heterozygous Runx3 VWRPYϪ mice onto a PGK-Cre transgenic mice (ref. 32 ; Fig.  1 A) . RT-PCR and Western blot analyses were used to demonstrate expression of Runx3 VWRPYϪ mRN〈 and protein ( Fig. 1 B and C) . The absence of VWRPY motif in Runx3 protein, derived from the mutant allele, was confirmed by using antibodies specific to the VWRPY pentapeptide (Fig. 1C) . Immunohistochemistry on sections from Runx3 VWRPYϪ/Ϫ mice, homozygous to the VWRPY minus mutant allele, revealed thymus architecture and staining pattern of Runx3 VWRPYϪ that were similar to WT (Fig. 1D) .
Previous studies showed that newborn Runx3 Ϫ/Ϫ mice had sensory ataxia, due to the death of TrkC ϩ neurons in DRG, and that mice displayed a reduced growth rate (8, 9) . In contrast, Runx3 VWRPYϪ/Ϫ mice had an apparent phenotype indistinguishable from WT mice; they were not ataxic and displayed normal growth (Fig. 1E) . Further analysis showed that contrary to Runx3 Ϫ/Ϫ mice, which lack expression of Runx3 (9), expression of Runx3 VWRPYϪ protein in DRG of Runx3 VWRPYϪ/Ϫ mice was similar to that in WT mice (Fig. 1F) , indicating that TrkC ϩ neurons in Runx3 VWRPYϪ/Ϫ mice are viable. More convincingly, immunostaining of the calciumbinding protein parvalbumin, a marker of TrkC ϩ neurons (9, 33), gave a similar pattern in DRG from WT and Runx3 VWRPYϪ/Ϫ mice (Fig. 1F) . We conclude that Runx3 VWRPYϪ is capable of supporting neurogenesis of TrkC ϩ neurons when expressed from its endogenous locus and that Runx3 capacity to recruit Gro͞TLE is not essential for this process.
Enhanced Spontaneous Maturation of Runx3 VWRPY؊/؊ DC. In addition to its function in fate determination of DRG sensory neurons, Runx3 plays a role in development and maturation of skin LC and tissue DC, where it functions as a component in TGF-␤ signaling pathway (7) . TGF-␤ plays a dual role in the LC͞DC compartment: it promotes development of epidermal LC and inhibits maturation of DC. When Runx3 function was lost, Runx3 Ϫ/Ϫ mice lacked epidermal LC, and their DC did not respond to TGF-␤-induced maturation inhibition and spontaneously matured (7) . Unlike Runx3 Ϫ/Ϫ , skin epidermis of Runx3 VWRPYϪ/Ϫ mice contained abundant LC similar to WT littermate mice ( Fig. 2A) . But in contrast to WT DC, which exhibited a low level of spontaneous maturation, a substantial proportion (Ϸ50%) of Runx3 VWRPYϪ/Ϫ DC spontaneously matured, resembling the Runx3 Ϫ/Ϫ phenotype (Fig. 2B) . Even exogenously added TGF-␤ did not completely inhibit the spontaneous maturation of Runx3 VWRPYϪ/Ϫ DC (Fig.  2C) . Thus, Runx3 VWRPYϪ activity was sufficient to promote TGF-␤-dependent development of skin LC but was insufficient to promote TGF-␤-induced maturation inhibition of DC. These data show that during LC͞DC development, Runx3 mediates both positive and negative cues of TGF-␤, some of which require engagement of Gro͞TLE.
Runx3-Mediated Silencing of the CD4 Gene Requires Recruitment of
Gro͞TLE. During thymopoiesis, CD4
ϩ CD8 ϩ double-positive thymocytes differentiate into mature single-positive (SP) CD4 ϩ or SP CD8 ϩ cells (34) . In SP CD8
ϩ cells, the expression of CD4 is transcriptionally repressed (30, 35) . A region of 430 bp, known as the CD4 silencer, is required for this process (29, 30, (36) (37) (38) . This silencer encompasses two functional Runx-binding sites, which are essential for the irreversible epigenetic silencing of CD4 in mature SP CD8 ϩ cells (11, (28) (29) (30) . Runx3 is highly expressed in SP CD8 ϩ and, when lost, transcriptional silencing of CD4 is impaired, leading to accumulation of an abnormal population of mature CD8 ϩ T cells in which expression of CD4 is not repressed (11, 12, 21) .
We assessed the distribution of CD4͞CD8 among mature (TCR high HSA Ϫ/low ) T cells in thymus and spleen of Runx3 VWRPYϪ/Ϫ mice in comparison with that of WT and Runx3 Ϫ/Ϫ mice. A profound increase in the proportion of mature CD8 ϩ T cells that also expressed CD4 was observed in both thymus and spleen of Runx3 VWRPYϪ/Ϫ mice compared with WT mice (Fig.  3 A) . The distribution of mature CD4 ϩ ͞CD8 ϩ thymocytes in Runx3 VWRPYϪ/Ϫ mice was similar to that in Runx3 Ϫ/Ϫ mice and markedly different from that in WT mice (Fig. 3A Upper; refs. 11 and 12). Interestingly, among splenocytes, the frequency of CD4 ϩ CD8 ϩ in Runx3 VWRPYϪ/Ϫ mice was even higher than that in Runx3 Ϫ/Ϫ mice (Fig. 3 A Lower) . The average (n ϭ 5) frequency of CD4 ϩ CD8 ϩ splenic T cells in Runx3 VWRPYϪ/Ϫ and Runx3 Ϫ/Ϫ mice was 12.0 Ϯ 4.4% and 6.4 Ϯ 2.4%, respectably, compared with 0.67 Ϯ 0.2% in WT mice (Fig. 3B) . These data unequivocally show that silencing of CD4 by Runx3 requires the recruitment of the corepressor Gro͞TLE. It also indicates that CD4 expression was significantly less repressed in CD8 ϩ splenocytes of Runx3 VWRPYϪ/Ϫ mice as compared with splenocytes of Runx3 Ϫ/Ϫ mice. Using transfection assays, we also assessed the ability of Runx3 to negatively regulate the CD4 silencer in conjunction with Gro͞ TLE. Reporter constructs, in which human elongation factor promoter, with or without CD4 silencer, regulate luciferase (luc) transcription, were cotransfected into two cell lines (COS-7 and HEK-293) with constructs expressing TLE1 (CMV-TLE1) and constructs expressing either WT Runx3 (CMV-Runx3) or mutant Runx3 (CMV-Runx3 VWRPYϪ ) (Fig. 6 , which is published as supporting information on the PNAS web site). WT Runx3 was significantly more active than Runx3 VWRPYϪ in reducing CD4 silencer-derived luc activity (Fig. 6 ), indicating that in the context of the CD4 silencer, Runx3-mediated transcriptional repression largely depends on its ability to tether Gro͞TLE.
Besides silencing of CD4, Runx3 also regulates other CD8-T cell-specific genes (39, 40) . Hence, in the absence of Runx3 function, proliferative capacity of peripheral Runx3 Ϫ/Ϫ CD8 ϩ T cells was impaired, resulting in a profound reduction in the proportion of splenic CD8 ϩ T cells ( Fig. 3A; refs. 11 and 12 ). In contrast, no significant difference in proportion of CD8 ϩ T cells (Fig. 3A) or in cell proliferation ability (Fig. 3D) was noted between Runx3 VWRPYϪ/Ϫ and WT. These data show that in developing 
CD8
ϩ T cells, silencing of CD4 and cell proliferative capacity are two independent Runx3-mediated processes. When Runx3 ability to recruit Gro͞TLE is lost, repression of CD4 is impaired, but cell proliferation remains intact, underscoring the fact that Runx3 can function as a positive regulator in one context and as a negative regulator in another.
Runx3 in Conjunction with Gro͞TLE Down-Regulates ␣E͞CD103 in
Peripheral CD8 ؉ T Cells. Grueter et al. (27) have recently shown that Runx3 positively regulates the expression of the ␣E͞CD103 integrin during T cell development and that knockdown of Runx3 markedly reduced the frequency of ␣E͞CD103-expressing CD8 ϩ T cells. ␣E͞CD103 mediates the interaction with E-cadherin on epithelial cells and is normally expressed on 80-90% of mature CD8 ϩ thymocytes and on a much lower proportion (40-50%) of CD8 ϩ splenocytes (27, 41) .
We assessed the ability of Runx3 VWRPYϪ to positively regulate expression of ␣E͞CD103. More than 90% of SP CD8 ϩ thymocytes in WT and Runx3 VWRPYϪ/Ϫ mice expressed ␣E͞CD103 compared with Ͻ10% in Runx3 Ϫ/Ϫ mice (Fig. 4A ). This finding is not only consistent with data obtained by Grueter et al. (27) , but it also implies that similarly to WT, Runx3 VWRPYϪ can positively regulate the expression of ␣E͞CD103. Compared with thymocytes, there was a lower proportion of CD8 ϩ CD103 ϩ splenocytes in WT mice and even lower proportion in Runx3 Ϫ/Ϫ mice (Fig. 4B) , in full agreement with the published data (27) . Strikingly, however, in Runx3 VWRPYϪ/Ϫ mice, the proportion of CD8 ϩ CD103 ϩ splenocytes was not reduced compared with thymocytes, and Ͼ90% of Runx3 VWRPYϪ/Ϫ splenocytes expressed CD103 (Fig. 4B) . In fact, the ratio of CD103 ϩ ͞CD103 Ϫ splenocytes in Runx3 VWRPYϪ/Ϫ mice was Ϸ9-fold higher compared with WT, whereas in thymocytes, the ratio was similar (Fig. 4C) . Of note, the fact that Runx3 VWRPYϪ/Ϫ splenocytes express higher-than-WT levels of ␣E͞CD103 implies that the normally reduced expression of ␣E͞CD103 in splenic CD8 ϩ T cells (27, 41) is not due to a pause in transcriptional activation but rather to a down-regulation of ␣E͞CD103 expression. These data show that in peripheral CD8 ϩ T cells, Runx3, in conjunction with Gro͞TLE, down-regulates ␣E͞CD103 expression. This conclusion is further supported by the marked decline of ␣E͞CD103 expression that was observed in proliferating cultured splenocytes from WT but not from Runx3 VWRPYϪ/Ϫ mice (Fig. 7 , which is published as supporting information on the PNAS web site). Thus, during development of CD8-lineage T cells, Runx3 functions both as a positive and negative regulator of the same gene and must recruit Gro͞TLE to accomplish the transition.
We next asked whether Runx3 directly regulates ␣E͞CD103 transcription. ␣E͞CD103 is a heterodimer composed of the ␣E and ␤7 chains. Because the ␤7 chain is highly expressed in T cells, the limiting factor in ␣E͞CD103 expression is the transcription of the ␣E gene (42) . We used RT-PCR to monitor ␣E transcription in thymocytes and splenocytes of WT, Runx3 VWRPYϪ/Ϫ , and Runx3 Ϫ/Ϫ mice (Fig. 4D) . The loss of Runx3 did not completely abolish ␣E transcription in CD8 ϩ thymocytes or splenocytes (Fig.  4D) , as also evidenced by the low, yet detectable, surface expression 
of ␣E͞CD103 in Runx3
Ϫ/Ϫ thymocytes and splenocytes (Fig. 4 B  and C) . However, in comparison with WT splenocytes, the ␣E transcription level in Runx3 VWRPYϪ/Ϫ splenocytes was significantly higher, whereas in thymocytes, the level was similar (Fig. 4D) . These ␣E transcription levels correlated well with ␣E͞CD103 surface expression (Fig. 4 B and C) . These results indicate that in CD8-lineage T cells, Runx3 controls ␣E͞CD103 expression through transcriptional regulation of the heterodimeric subunit ␣E. When Runx3 function is lost, ␣E͞CD103 expression in CD8 ϩ thymocytes and splenocytes diminished. However, when only the ability to recruit Gro͞TLE is lost, ␣E͞CD103 expression in thymocytes remains normal, but down-regulation in peripheral CD8
ϩ T cells is impaired, which attests to the crucial role of Runx3-Gro͞TLE in mediating the switch from transcriptional activation to repression.
Discussion
Through comparisons of biogenesis and function of TrkC neurons, LC͞DC and CD8 ϩ T lymphocytes in Runx3 VWRPYϪ/Ϫ , Runx3 Ϫ/Ϫ , and WT mice, we obtained unique insights into the bifunctional nature of Runx3 and into the mechanism by which it represses target genes. Whereas Runx3 could function as either transcriptional activator or transcriptional repressor (14, 28) , the phenotypic consequences of these opposing regulatory modes and how the transition from activation to repression occurs in the in vivo context of the animal have not been addressed. We found that in developing TrkC neurons, the ability of Runx3 to mediate transcriptional repression, in conjunction with Gro͞TLE, was not essential for the development of functional TrkC neurons. In contrast, in the LC͞DC compartment, where Runx3 functions as a component of TGF-␤ signaling cascade, recruitment of Gro͞TLE is required for proper maturation of DC but not for normal development of skin LC.
Analysis of Runx3 VWRPYϪ function in the CD8 T cell-lineage provided evidence that Runx3 regulates transcription of ␣E͞CD103 in opposing regulatory modes and that repression of both ␣E͞ CD103 and CD4 requires the binding of the corepressor, Gro͞TLE. Given that CD4 transcription in CD8 ϩ T cells is epigenetically repressed (11, 28, 30) , our data indicate that Runx3 involvement in epigenetic silencing of CD4 requires recruitment of Gro͞TLE. When Runx3 is lost or is unable to tether Gro͞TLE, CD4 is derepressed. But why is derepression of CD4 significantly higher in Runx3 VWRPYϪ/Ϫ splenic T cells as compared with Runx3 Ϫ/Ϫ cells? A possible explanation could be that while in Runx3 Ϫ/Ϫ cells, the loss of Runx3 is partially compensated by Runx1 activity (11, 30) , in Runx3 VWRPYϪ/Ϫ cells, such compensation is less efficient. We hypothesize that this phenomenon occurs because the mutant protein, which is unable to elicit repression but can still bind to the CD4 silencer's RUNX sites, outcompetes Runx1. As a result, Runx1 compensation diminishes, leading to the observed higher derepression of CD4 in Runx3 VWRPYϪ/Ϫ T cells compared with Runx3 Ϫ/Ϫ cells. This hypothesis is supported by findings that in a compound mutant mouse Runx3 Ϫ/Ϫ ͞Runx1 Ϫ/ϩ , i.e., null for Runx3 and hemizygous for Runx1, CD4 expression in CD8 ϩ T cells is completely derepressed and all peripheral CD8 ϩ T cells also expressed CD4 (12) .
How tethering of Gro͞TLE to target promoters͞silencers evokes transcriptional repression is not yet fully understood. However, as Gro͞TLE interacts with histones and histone deacetylases (18, 43) , it is likely that recruitment of Gro͞TLE by the DNA-bound Runx3 modulates local chromatin structure at the CD4 locus, resulting in a repressed transcriptional state (44) . Our data provide evidence for a Runx3-Gro͞TLE-mediated epigenetic silencing and pertain to the mechanism of Runx3-mediated repression and silencing of other genes (14) . Interestingly, repression of both ␣E͞CD103 and CD4 occurs in mature CD8 ϩ T cells and may reflect a cell stage-specific availability of components, such as chromatin modifications enzymes (18) required for Runx3-Gro͞TLE-mediated repression.
Previous studies have shown that the chromatin remodeling complexes BRG1-associated factor (BAF) are involved in transcriptional repression of CD4 during thymopoiesis (45, 46) . The available information on molecular events that lead to silencing of CD4 during CD8-lineage differentiation was recently integrated into a hypothetical model (30) . It predicts that CD4 repression in DP thymocytes is initiated by a step, which precedes the engagement of BAF and involves binding of Runx3 to the CD4 silencer and recruitment of another ''as-yet-unknown'' component, which facilitates histone deacetylation. Our data not only support this model but are also consistent with the possibility that Gro͞TLE constitutes the missing link. The average ratio and SE of CD103 ϩ ͞CD103 Ϫ in CD8 ϩ thymocytes (n Ͼ 3) and splenocytes (n Ͼ 5) of WT (blue), Runx3 VWRPYϪ/Ϫ (green), and Runx3 Ϫ/Ϫ (pink) mice. The average proportion of CD103 ϩ in CD8 ϩ splenocytes of Runx3 VWRPYϪ/Ϫ mice was significantly ( * ) higher than in WT mice (P ϭ 0.003). (D) Runx3 regulates ␣E͞CD103 expression through transcriptional regulation of the ␣E gene. RT-PCR (Upper) representative results of two and three independent experiments by using independently derived cDNAs of thymus and spleen RNA, respectively, are shown. In thymocytes, the level of ␣E transcript was similar in Runx3 VWRPYϪ/Ϫ and WT, whereas in splenocytes, it was higher in Runx3 VWRPYϪ/Ϫ compared with WT.
